NCT01044342View on ClinicalTrials.gov

A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Cognition

Interventions

DRUG

AZD1446

capsule; single oral dose

DRUG

AZD1446

capsule, single oral dose

DRUG

donepezil

capsule, single oral dose

DRUG

Placebo

capsule, single oral dose

Trial Locations (1)

Unknown

Research Site, Rouffach

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT01044342 - A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition | Biotech Hunter | Biotech Hunter